Dr. Richard Salvi
SUNY Distinguished Professor at the University at
preclinica and clinical trials
CILcare
France
Biography
Dr. Salvi is internationally known for his scientific work on the auditory system and a broad range of hearing disorders. Over the past 40 years, Salvi has published more than 400 papers, books, chapters and scientific reports and has organized more than a dozen international symposia and conferences. His research spans a broad range of topics that include noise-induced hearing loss, ototoxicity, age-related hearing loss, hair cell regeneration, tinnitus, hyperacusis and neural plasticity. His research investigations have involved a diverse range of experimental techniques including animal behavior, electrophysiology, anatomy, genomics, proteomics and brain imaging with humans and animals. Salvi is the Director of the Center of Hearing and Deafness at the State University of New York at Buffalo, a research institute that focuses on hearing impairments that affect the peripheral and central auditory system. Salvi’s current research interests include: (1) understanding the biological mechanisms underlying hearing loss (2) identifying the neural mechanism contributing to tinnitus and hyperacusis, (3) identifying drugs that can prevent, protect, restore hearing loss or suppress tinnitus, (4) central auditory system plasticity and (5) age-related hearing loss. Salvi will advise CILcare in the selection, set-up and the management of scalable preclinical models of normal hearing and hearing loss and will be accessible to drug developers for their last preclinical steps before moving in clinical trials. Having his experience supporting CILcare is a true honor. Dr. Salvi is internationally known for his scientific work on the auditory system and a broad range of hearing disorders. Over the past 40 years, Salvi has published more than 400 papers, books, chapters and scientific reports and has organized more than a dozen international symposia and conferences. His research spans a broad range of topics that include noise-induced hearing loss, ototoxicity, age-related hearing loss, hair cell regeneration, tinnitus, hyperacusis and neural plasticity. His research investigations have involved a diverse range of experimental techniques including animal behavior, electrophysiology, anatomy, genomics, proteomics and brain imaging with humans and animals. Salvi is the Director of the Center of Hearing and Deafness at the State University of New York at Buffalo, a research institute that focuses on hearing impairments that affect the peripheral and central auditory system. Salvi’s current research interests include: (1) understanding the biological mechanisms underlying hearing loss (2) identifying the neural mechanism contributing to tinnitus and hyperacusis, (3) identifying drugs that can prevent, protect, restore hearing loss or suppress tinnitus, (4) central auditory system plasticity and (5) age-related hearing loss. Salvi will advise CILcare in the selection, set-up and the management of scalable preclinical models of normal hearing and hearing loss and will be accessible to drug developers for their last preclinical steps before moving in clinical trials. Having his experience supporting CILcare is a true honor.
Research Interest
preclinica and clinical trials